Fungal biomass and fungal extract of the nonpathogenic fungus Neurospora crassa were successfully used as reducing agents for the biosynthesis of platinum nanoparticles (PtNPs). The experiment was carried out by exposing the fungal biomass or the fungal extract to a 0.001 M precursor solution of hexachloroplatinic(IV) acid (H 2 PtCl 6 ). A change of color of the biomass from pale yellow to dark brown was the first indication of possible formation of PtNPs by the fungus. Subsequent analyses confirmed the intracellular biosynthesis of single PtNPs (4-35 nm in diameter) and spherical nanoaggregates (20-110 nm in diameter). Using the fungal extract, similar results were obtained, producing rounded nanoaggregates of Pt single crystals in the range of 17-76 nm.
Nanotechnology has become one of the most important and exciting research fields in physics, chemistry, and engineering materials [17] . Nowadays, there is great interest in the production of inorganic nanoparticles (NPs), because of a wide spectrum of applications, such as catalysts [7] semiconductors [11] , optical devices, biosensors [3] , encapsulation of drugs, and contrast agents [14] among others. Therefore, an important area of study in nanotechnological research is the synthesis of nanoparticles (NPs) with specific chemical composition, shape, and size [2] .
Currently, the synthesis of most metal NPs is based on chemical and physical processes, which are highly toxic and/or involve high energy costs, high temperature, pressure, and pH [20] . On the other hand, in nature, some organisms have the ability to biosynthesize inorganic materials, like the diatoms that synthesize silica [10] and the magnetostatic bacteria that can synthesize magnetite [5] . Consequently, in modern nanotechnology, scientists have been exploring the use of biological systems as potentially eco-friendly nanofactories. The development of environmentally safe synthetic processes, based on biological systems, is currently a subject of study in several countries [23] . The use of this type of alternative method offers a number of advantages, including a significant reduction of waste products and a decrease in production costs [15] .
The synthesis of NPs by the use of biological systems has been reported for noble metals such as gold and silver [2, 8, 15, 24, 25] , but little is known about biological reduction with metals like platinum [9] . Platinum nanoparticles (PtNPs) offer the possibility of use in various areas, such as in the development of fuel cells with higher performance at lower costs in the automotive industry [18] , in catalysis [13] , and in medicine, among others. For example, one of the first studies to use a biological agent to produce PtNPs employed the bacterium Shewanella algae, which formed nanoparticles within 60 min at room temperature by reaction with [PtCl 6 ] 2-ions in aqueous solution [9] . Among the biological systems explored for the synthesis of metallic NPs, several fungal species have been tested, with the fungus Fusarium oxysporum being one of the most commonly employed biological agents [1, 2, 19] . It has been reported that the synthesis of NPs using this fungus occurs intracellularly and extracellularly by the presence of various enzyme complexes [2] . Highly stable PtNPs of 10-50 nm in diameter were obtained by the use of this organism [20] .
The biosynthesis of NPs by the use of filamentous fungi offers more advantages than other biological systems such as prokaryotes or plants. Among these advantages are their ability to resist pressure, agitation gradients, and other conditions during the reduction process. In addition, some species have fast growth rates, biomass is easy to handle, secrete proteins with enhanced reductive properties, and form highly stable particles, which prevent molecular aggregation [16, 17] .
Although filamentous fungi are abundant in nature, little is known about the capacity of these microorganisms to carry out pure and stable biosynthesis processes for the production of metallic NPs. The filamentous fungus Neurospora crassa is widely used as a model organism in which an understanding of cell biology, molecular biology, and biochemistry have greatly advanced in recent years. This fungus is easy to culture and maintain in the laboratory, and its growth rate is high compared with that of other fungal species. In addition, it is considered a nonpathogenic species. Neurospora is also a very attractive organism to explore as a reducing agent for the production of metallic nanoparticles. Therefore, the objective of this study was the development of a convenient method to synthesize PtNPs, using this organism and its extract as reducing agents.
MATERIALS AND METHODS

Synthesis of Platinum Nanoparticles
Neurospora crassa wild-type strain was obtained from the Fungal Genetics Stock Center (strain #9013) and was grown in Erlenmeyer flasks with Vogel's minimal medium (VMM) [26] supplemented with 2% (w/v) sucrose as a carbon source and solidified with 1.5% agar (w/v). Cultures were maintained under lighted conditions at 28 o C for 5 to 10 days to obtain macroconidia, which were harvested and maintained in glycerol at 4 o C until needed. Fungal biomass was obtained by inoculating 100 µl of N. crassa macroconidia in Erlenmeyer flasks containing 100 ml of potato dextrose broth (PDB). Cultures were incubated for 24 h at 28 o C in an orbital shaker (Orbiton Environ Shaker) at 200 rpm. Biomass was harvested by filtration (paper filter #410 VWR) and was washed three times with sterile distilled water to remove excess nutrients.
For the reduction process, washed biomass was resuspended in 100 ml of an aqueous solution of hexachloroplatinic(IV) acid (0.001 M H 2 PtCl 6 ; Sigma-Aldrich) for 24 h under dark conditions. The mixture and a control culture containing fungal biomass in deionized water were incubated simultaneously for 24 h at 28 o C in the shaker at 200 rpm. To determine the characteristic absorption spectra of PtNPs, aliquots from solutions of both cultures were analyzed with a UVvis spectrophotometer (Varian, model Cary-300). After the incubation period, the mycelium was separated from the aqueous solution by filtration. After the absorption peak was determined, small fragments of the mycelia were scanned under confocal microscopy. The resulting biomass (10-15 g, wet weight) was lyophilized for extraction of NPs and subsequent TEM analysis. To prepare PtNPs using the fungal extract, 12 g of freshly harvested and washed biomass was ground in a mortar with 25 ml of deionized water. The mixture was centrifuged at 5,000 rpm for 5 min and decanted and mixed in a 2:1 proportion with an aqueous 0.001 M solution of hexachloroplatinic(IV) acid. After the solution was incubated in the dark for 24 h at ambient conditions, small drops were placed on carbon-coated Cu grids and analyzed by TEM. Confocal microscopy of fungal cells was carried out with an inverted Zeiss Laser Scanning Confocal Microscope LSM-510 META. Confocal images were obtained using LSM-510 software (version 3.2; Carl Zeiss) and evaluated with an LSM-510 image examiner (version 3.2). The presence of metallic material was determined with an Argon-2 laser, Abs/Em 488/515-530 nm.
Characterization of Platinum Nanoparticles PtNPs were extracted from dry biomass that had been ground in a mortar agate and approximately 0.05 g of the powder was placed in a 10 ml beaker with 5 ml of deionized water and dispersed in a sonicator (Bransonic B-220) for 10 min. The homogenized material was centrifuged at 5,000 rpm for 5 min and the resulting supernatant was decanted. The sample was suspended in 1 ml of isopropyl alcohol (2-propanol) and sonicated for another 10 min, after which 10 µl of the resulting solution was placed on a carbon-coated copper grid and allowed to dry at ambient temperature. The size and shape of PtNPs were determined by transmission electron microscopy (TEM) with a JEOL 2010 and a FEI Tecnai F30, operated at 200 and 300 kV, respectively. Energy dispersive spectroscopy (EDS) was carried also out on the Tecnai F30 TEM. The size distribution of the nanoaggregates was determined with the JMicroVision software.
Thin Fungal Sections Analysis
To determine the intracellular presence of PtNPs in N. crassa, thin sections of hyphae were analyzed by TEM. After 24 h of incubation with platinum ions, biomass was prefixed for 2 h in 2% glutaraldehyde in 0.05 M sodium phosphate and prepared as described previously [4] . Briefly, biomass was washed after fixation with 0.05 M sodium phosphate and then dehydrated in ethanol series. Afterwards, samples were infiltrated and embedded in Spurr's resin. Ultrathin sections (70 nm) were obtained with an ultramicrotome (Leica Ultracut R) and were recovered on copper TEM grids. Sections were examined with a Hitachi H-7500 TEM at 100 kV without post-staining.
RESULTS AND DISCUSSION
Fungal biomass and fungal extract of N. crassa were successfully used as reducing agents for the formation of PtNPs, which were obtained after 24 h of incubation. Changes in color of the precursor solution and of the fungal biomass were observed after the completion of the reaction. Initially, the precursor solution was light yellow (Fig. 1A) , but after 24 h of reaction with the fungal biomass, the solution became colorless after removing the mycelium (Fig. 1B) . Biomass of N. crassa is typically pale orange (Fig. 1, inset A ), but after reaction with H 2 PtCl 6 it became dark brown (Fig. 1, inset B) . To the unaided eye, these changes in color are the first indication of the intracellular formation of PtNPs [9] . Analysis of the unfiltered supernatant (containing small amounts of biomass) by UV-vis spectrophotometry reveals an absorption shoulder at 460 nm (data not shown). Maximum absorption intensity for PtNPs depends upon size and the reaction medium [12, 21] . Optical properties of PtNPs change when they form agglomerates, such that the absorption spectra become flatter and broader and the maxima appear at longer wavelengths than those observed for isolated particles [21] . In the case of isolated PtNPs, the absorption band appears typically around 260 nm; therefore, the absorption peak of 460 nm resulted from our unfiltered supernatant samples suggests the presence of agglomerated platinum particles within the fungal biomass. A strong fluorescence inside the N. crassa hypha was observed, indicative of an intracellular distribution of PtNPs (Fig. 1C) . After the reduction process, examination of the filtered supernatant by TEM showed no evidence of NPs. This indicates that formation of PtNPs occurred only intracellularly.
Results from thin sections of N. crassa hyphae corroborated the presence of PtNPs within the fungal cell. Representative images are shown in Fig. 2A-B . At lower magnification, the presence of NPs was somewhat evident within the cell wall, and also in the cytoplasm ( Fig. 2A) . At higher magnification, it was confirmed that NPs are concentrated in the cell, and that significant aggregations are present inside the cytoplasm (Fig. 2B, white arrow) . The accumulation of NPs in the cell wall of fungi has been previously reported [27] , and although it is not yet understood which molecules are involved in the bioreduction and stabilization process, it is known that proteins are the primary biomolecules involved in the process [22, 27] . Higher resolution microscopy showed that most PtNPs are quasi-spherical (Fig. 2C ) and single-crystalline ( Fig. 2D ) with dimensions between 4 and 35 nm (about 70% of these are between 5 and 10 nm, with a mean size of 11.7 ± 7.1 nm). As expected from the absorption peak obtained, we also found nanoaggregates composed of many individual single crystal PtNPs (Fig. 2E ) with dimensions between 20 and 110 nm with a mean size of 53 ± 23 nm. By using the fungal extract as a reducing agent, mostly round nanoaggregates are obtained (Fig. 3A) , with dimensions between 17 and 76 nm. As shown in Fig. 3B , they appear to consist of many perfect single crystals of PtNPs. Despite differences in size, these NPs have crystallized as highly uniform, quasi-spherical solids. The protocol using fungal extract was repeated three times in order to verify reproducibility and the results obtained showed no significant difference (P>0.05). In all cases, there were no aggregations of NPs greater than ~110 nm in diameter, which is probably due to the inherent stability of the biological molecules [2, 6] . Fig. 4A is a wide-area, dark-field image showing the particles. Chemical analysis of these particles was carried out along the trace marked by the red line in Fig. 4A . EDS spectra (such as that shown in Fig. 4B ) were recorded along the trace. The variation in intensity (concentration) of C, Pt-M, and Pt-L peaks is plotted in Fig. 4C , highlighting the 3 Pt particles. The analysis revealed that the bright particles in Fig. 4A contain high concentrations of platinum, consistent with the reductive capacity of the N. crassa extract. It should be noted that the presence of carbon is attributable to the "lacey-carbon" support and from organic residue from the fungus. The copper signal corresponds to the Cu-grid used for the TEM observations. Size distribution of the nanoaggregates was determined from dark-field images, such as the one shown in Fig. 4A . A total of 234 particles were measured. Sixty percent of the PtNPs had a diameter between 40 and 50 nm (see Fig. 5 ), whereas only 2% of this group of nanoparticles had a diameter greater than 70 nm.
In conclusion, we report for the first time that by using N. crassa fungus, it is possible to produce PtNPs under ambient conditions. By this method, we can obtain single crystals of PtNPs with diameters of 4 to 35 nm, and agglomerates with diameters between 20 and 110 nm. However, if we use only the fungal extract, we obtain almost exclusively round single-crystal nanoagglomerates with diameters of 17 to 76 nm, containing individual single crystals of approximately 2-3 nm in diameter.
